Biosynex (ALBIO) — Cash Flow Quality Index
Latest as of June 2022:
0.19x
Biosynex (ALBIO) has a Cash Flow Quality Index of 0.19x as of June 2022. Operating cash flow of €5.96 Million is below net income of €30.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Biosynex cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.19x
Operating CF / Net Income
Operating Cash Flow
€5.96 Million
EUR
Net Income
€30.58 Million
EUR
Data as of
Jun 2022
Most recent filing
Biosynex Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Biosynex across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ALBIO cash generation efficiency.
Annual Cash Flow Quality Index for Biosynex (2017–2022)
Year-by-year earnings quality comparison for Biosynex.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.32x | €4.95 Million | €15.61 Million | ▼ -69.2% |
| 2021 | 1.03x | €109.83 Million | €106.68 Million | ▲ +2.1% |
| 2020 | 1.01x | €31.64 Million | €31.37 Million | ▼ -53.2% |
| 2019 | 2.15x | €1.10 Million | €512.31K | ▲ +150.5% |
| 2018 | 0.86x | €467.12K | €542.89K | ▼ -44.1% |
| 2017 | 1.54x | €484.82K | €315.22K | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.